Search

Start typing to see results...

Today Market

Stock Performance

Today Market

Today's High

78,757.40

Todday's Low

78,377.07

Open at

78,516.08

Previous Close

78,954.76

Volumes

Avg Price

-455.59

Historical Performance

News

03 Aug 26
GSK India’s revenue rose 15% to INR 924 crores in Q1 2026, PAT up 24%
GlaxoSmithKline Pharmaceuticals Ltd (GSK India) announced a 15% year-over-year increase in revenue to INR 924 crores for the first quarter ended June 30, 2026, with Profit After Tax (PAT) rising 24% to INR 253 crores, according to a press release issued Tuesday.
03 Aug 26
Glaxosmithkline Pharmaceuticals Ltd consolidated sales down 5.71% on year in Q2FY2026, net profit dropped 14.64%
Glaxosmithkline Pharmaceuticals Ltd share price gained 1.68% to Rs 2653.45. The Company's net profit contracted by 14.
22 Jul 26
GlaxoSmithKline Pharmaceuticals to table results
GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 3 August 2026.
06 Jul 26
Volumes soar at Glaxosmithkline Pharmaceuticals Ltd counter
Syngene International Ltd, Voltas Ltd, Cera Sanitaryware Ltd, Sun TV Network Ltd are among the other stocks to see a surge in volumes on BSE today, 06 July 2026.

Historical Prices

Share Price Chart

Historical Share Price

Date Open Price (₹) High Price(₹) Low Price(₹) Close Price(₹) Total Volume No of Trades Net Turnover(₹) NIFTY
07-08-26 2570.00 2624.90 2556.50 2599.70 34991 5023 91266429.10 24570.65
06-08-26 2546.90 2591.00 2540.50 2579.50 40361 6192 103896080.60 24636.00
05-08-26 2648.00 2650.20 2515.00 2569.70 51205 7645 132904083.80 24624.65
04-08-26 2680.20 2684.00 2601.30 2647.00 99739 13419 263393992.80 24614.90
03-08-26 2665.40 2670.00 2630.00 2662.30 89406 15660 237414521.40 24774.30
31-07-26 2617.90 2679.00 2564.70 2655.40 118467 18101 311600152.60 24383.60
30-07-26 2616.00 2639.40 2591.30 2610.70 68326 17663 178437856.70 24317.15
29-07-26 2645.90 2670.00 2609.00 2626.40 59537 10976 156938608.10 24250.20
28-07-26 2553.90 2669.00 2538.80 2632.60 101759 13117 265573827.60 23985.35
27-07-26 2524.00 2563.80 2494.10 2551.20 67921 12374 172281487.20 23995.95

Fundamentals

Company Valuation

Market Cap (₹cr)

43927.83

PE Ratio

41.5

PB Ratio

19.60

Dividend Yield

2.2

ROE

48.29

ROCE

58.17

Book Value (₹)

132.2958859

Face Value (₹)

10

Share Holding Pattern

Category of Shareholder No of Shares % Share Holdings Demat Shares Share Holders
plus  Promoter & Group
plus  Foreign
Foreign (Promoter & Group) - Bodies Corporate 127054524 75.00 127054524 4
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 127054524 75.00 127054524 4
plus  Indian
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 0 0.00 0 0
Total ShareHolding for Promoter & Group 127054524 75.00 127054524 4
plus   Publice Share Holding
plus  Institution
Government(Central / State) 94 0.00 94 2
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 18086 0.01 11084 19
Foreign Bank 1811 0.00 1811 2
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 8107430 4.79 8107430 242
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 4689441 2.77 4689441 16
Mutual Funds / UTI 8245074 4.87 8231954 36
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 262315 0.15 249431 18
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 21324251 12.59 21291245 335
plus  Non Institution
Bodies Corporate 1316774 0.78 1304678 950
Clearing Members 353 0.00 353 3
Directors & their Relatives 600 0.00 600 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 881657 0.52 874813 4175
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 423852 0.25 423852 2435
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 371374 0.22 371374 12
Individuals holding nominal share capital up to Rs. 1 lakh 16932867 10.00 15854080 118143
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 39537 0.02 39537 28
Others 1060245 0.63 1060245 1
Sub Total 21027259 12.41 19929532 125748
Total Public Shareholding 42351510 25.00 41220777 126083
Total of Promoter & Public ShareHolding 169406034 100.00 168275301 126087
plus  Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total 169406034 100.00 168275301 126087

Financials (₹ in cr)

Year EndMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Net Sales3,821.673,749.213,453.713,251.723,278.03
OPM (%)36.2533.4827.7925.7523.41
OP1,385.391,255.19959.80837.37767.47
Other Income145.36145.93122.59100.6675.78
PBIDT1,475.191,327.98887.67903.98849.23
INTEREST2.731.311.801.812.00
PBDT1,472.461,326.67885.87902.17847.23
PBT1,426.641,264.57672.57835.43790.62
EO20.634.69-143.62-0.9711.58
PBT after EO1,406.011,259.88816.19836.40779.05
TAXES370.03332.30226.23228.76398.28
PAT1,035.98927.58589.96610.691,694.72
EPS61.1554.7634.8336.05100.04
Raw Material11.4113.3315.7913.1518.64
Power and Fuel0.790.800.860.910.85
Employee Cost15.8915.4618.0818.3018.62
Other Manufacturing Expenses1.852.192.472.272.85
Selling and Administration Expenses9.5910.2410.8511.3910.48
Miscellaneous Expenses1.461.941.972.111.77
Revenue (Growth %) 1.938.566.21-0.8012.05
PBIDT (Growth %)11.0849.60-1.806.4558.40
PAT (Growth %) 11.6957.23-3.39-63.97373.19
PBIDT (Margin %)38.6035.4225.7027.8025.91
PAT (Margin %) 27.1124.7417.0818.7851.70

Balance Sheet (₹ in cr)

Particulars (Sources Of Funds)Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Share Capital 169.41169.41169.41169.41169.41169.41
Reserves Total 2071.771779.821614.691583.592508.211327.71
Equity Share Warrants0.000.000.000.000.000.00
Equity Application Money0.000.000.000.000.000.00
Total Shareholders Funds2241.181949.231784.101753.002677.621497.12
Secured Loans 0.000.000.000.000.000.00
Unsecured Loans 33.279.9518.6715.5420.0834.63
Total Debt33.279.9518.6715.5420.0834.63
Other Liabilities259.36248.40246.30254.22263.00260.29
Total Liabilities2533.812207.582049.072022.762960.701792.04
APPLICATION OF FUNDS :
Gross Block 700.21668.95683.12635.93593.89602.89
Less : Accumulated Depreciation 419.48385.31361.86305.99263.26216.00
Less:Impairment of Assets0.000.000.000.000.000.00
Net Block 280.73283.64321.26329.94330.63386.89
Lease Adjustment0.000.000.000.000.000.00
Capital Work in Progress32.9314.3213.9320.3130.5013.21
Producing Properties0.000.000.000.000.000.00
Investments 1416.321142.74837.72542.78390.0924.49
Current Assets, Loans & Advances
Inventories 430.35463.17514.30437.70512.71523.34
Sundry Debtors 273.11292.55222.06192.38205.24215.60
Cash and Bank Balance1354.791400.891061.201150.732479.111157.68
Loans and Advances 93.90108.70155.08167.62108.05274.71
Total Current Assets2152.162265.301952.621948.433305.122171.33
Less : Current Liabilities and Provisions
Current Liabilities 777.26952.43806.64590.941046.53866.70
Provisions 963.85940.93692.10713.99615.36438.35
Total Current Liabilities & Provisions1741.111893.361498.741304.941661.901305.05
Net Current Assets411.05371.95453.88643.491643.22866.28
Miscellaneous Expenses not written off 0.000.000.000.000.000.00
Deferred Tax Assets145.53155.99163.08151.38131.67117.24
Deferred Tax Liability11.9115.3517.1418.2018.8915.57
Net Deferred Tax133.62140.64145.94133.18112.78101.67
Other Assets259.16254.30276.33353.06453.48399.49
Total Assets2533.812207.582049.052022.762960.701792.03
Contingent Liabilities512.59453.28384.15350.59351.10485.78

Cash Flow (₹ in cr)

Yearly Cash FlowMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Financing Activities -524.24-1,544.18-561.50-769.42-737.07
Investing Activities -419.66805.1914.97-36.53385.25
Net Cash Flow -124.11-251.0532.41474.07529.60
Operating Activities 819.79487.94578.941,280.03881.42

Corporate Actions

DateCorporate ActionInformation
No Corporate Actions Announced

Board of Directors

Chairman & Chief Executive Officer
RSK
Renu S. Karnad
Chairman & Non Executive Dir.
Executive
Functional Directors
BA
Bhushan Akshikar
Managing Director
MD
RB
Ronojit Biswas
Whole Time Director & CFO
Dir.
KJF
Karine J F Natland
Non Executive Director
Exec.
Independent Directors
MA
Manu Anand
Independent Non Exe. Director
Ind.
SM
Sunita Maheshwari
Independent Non Exe. Director
Ind.
SP
Somasundaram Palamadairamaswamy
Independent Non Exe. Director
Ind.
AW
Anup Wadhawan
Independent Non Exe. Director
Ind.
Company Secretary & Compliance
AAN
A A Nadkarni
VP / Company Secretary / Compliance Officer
Sec.

Frequently Asked Questions

What is the NSE symbol and BSE code for Glaxosmithkline Pharmaceuticals Ltd?

Glaxosmithkline Pharmaceuticals Ltd trades on NSE under GLAXO and on BSE under code 500660. The ISIN is INE159A01016 and the face value is Rs 10.

What is the share price of Glaxosmithkline Pharmaceuticals Ltd today? +

As of 08 August 2026, Glaxosmithkline Pharmaceuticals Ltd trades at Rs 2,599.70, a change of 20.20 (0.78%) on the day. Prices are live and subject to change.

What is the market capitalisation of Glaxosmithkline Pharmaceuticals Ltd? +

As of 08 August 2026, Glaxosmithkline Pharmaceuticals Ltd has a market cap of about Rs 43927.83 crore. This figure is live and moves with the share price.

Is Glaxosmithkline Pharmaceuticals Ltd profitable? +

In March 2026, Glaxosmithkline Pharmaceuticals Ltd reported a profit after tax of Rs 1,035.98 crore. The wording switches to "a net loss of Rs X crore" when the figure is negative.

What is the PE ratio of Glaxosmithkline Pharmaceuticals Ltd? +

: As of 08 August 2026, the PE (TTM) for Glaxosmithkline Pharmaceuticals Ltd is 41.5 and the price-to-book ratio is 19.60. When the PE shows zero, state that PE TTM is currently not applicable and give the PB only.

Does Glaxosmithkline Pharmaceuticals Ltd pay a dividend? +

As of 08 August 2026, the dividend yield for Glaxosmithkline Pharmaceuticals Ltd is 2.2%. The wording switches to "does not currently pay a dividend" when the yield is zero.

What is the shareholding pattern of Glaxosmithkline Pharmaceuticals Ltd? +

As of the latest disclosed pattern, promoters hold 75.00% of Glaxosmithkline Pharmaceuticals Ltd. Public shareholding is 25.00%, including mutual funds at 4.87% and foreign institutional investors at 4.79%.

What were the latest annual financials of Glaxosmithkline Pharmaceuticals Ltd? +

In March 2026, Glaxosmithkline Pharmaceuticals Ltd reported net sales of Rs 3,821.67 crore, revenue growth of 1.93%, and earnings per share of Rs 61.15.
We are hiring! Check out open positions and send your CV to csecrecruit@chola.murugappa.com
Pre-Apply for IPOs
Chola Securities App
Install
🌐
Stay on Web